StreetInsider.com News Articles http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 10 Apr 2024 07:13:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif StreetInsider.com News Articles http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Wed, 10 Apr 2024 07:13:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Wed, 10 Apr 2024 07:13:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Wed, 10 Apr 2024 07:13:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Wed, 10 Apr 2024 07:13:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Wed, 10 Apr 2024 07:13:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html for the full story. http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Wed, 10 Apr 2024 07:13:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html for the full story. http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Wed, 10 Apr 2024 07:13:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html for the full story. http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Wed, 10 Apr 2024 07:13:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html for the full story. http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Wed, 10 Apr 2024 07:13:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html for the full story. http://www.streetinsider.com/PRNewswire/Gabather+Joins+Forces+with+the+Centre+for+Neuropsychiatric+Schizophrenia+Research+in+Denmark+to+Conduct+a+Clinical+Phase+II+Study+with+GT-002/23048958.html Wed, 10 Apr 2024 07:13:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Mon, 18 Mar 2024 03:46:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Mon, 18 Mar 2024 03:46:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Mon, 18 Mar 2024 03:46:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Mon, 18 Mar 2024 03:46:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Mon, 18 Mar 2024 03:46:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html for the full story. http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Mon, 18 Mar 2024 03:46:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html for the full story. http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Mon, 18 Mar 2024 03:46:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html for the full story. http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Mon, 18 Mar 2024 03:46:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html for the full story. http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Mon, 18 Mar 2024 03:46:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html for the full story. http://www.streetinsider.com/PRNewswire/Gabather+files+two+new+patent+applications+to+secure+novel+findings+on+the+effects+of+GT-002+for+the+treatment+of+psychiatric+disorders/22941351.html Mon, 18 Mar 2024 03:46:00 -0400 GABA GABA GABA O.01114982 O.17799561 Gabather reports initial positive results from the EEG/fMRI target engagement study http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html Thu, 07 Mar 2024 03:18:00 -0400 GABA GABA GABA GABA O.01114982 O.17799561 Gabather reports initial positive results from the EEG/fMRI target engagement study http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html Thu, 07 Mar 2024 03:18:00 -0400 GABA GABA GABA GABA O.01114982 O.17799561 Gabather reports initial positive results from the EEG/fMRI target engagement study http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html Thu, 07 Mar 2024 03:18:00 -0400 GABA GABA GABA GABA O.01114982 O.17799561 Gabather reports initial positive results from the EEG/fMRI target engagement study http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html Thu, 07 Mar 2024 03:18:00 -0400 GABA GABA GABA GABA O.01114982 O.17799561 Gabather reports initial positive results from the EEG/fMRI target engagement study http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html for the full story. http://www.streetinsider.com/Press+Releases/Gabather+reports+initial+positive+results+from+the+EEGfMRI+target+engagement+study/22896902.html Thu, 07 Mar 2024 03:18:00 -0400 GABA GABA GABA GABA O.01114982 O.17799561